FMC Corporation is experiencing severe financial challenges, with third-quarter revenue nearly wiped out due to structural pricing problems and excess distributor inventory leading to aggressive price cuts. These issues have squeezed profit margins and revealed the company's fragile balance sheet, with net debt remaining high between $3.3 billion and $3.6 billion. The outlook is concerning as 2026 EBITDA could approach zero, and leverage ratios are stretched compared to peers. Although FMC has promising new active ingredients and pipeline assets for the long term, its near-term valuation looks poor, and its stock value is highly sensitive to upcoming fourth-quarter results. Consequently, the rating has been downgraded from Buy to Hold.
FMC Corporation's stock is trading at USD 5.61 on Pluang, down 0.88% in the last day as of Oct 19, 2026 19:41 WIB. The company has a market cap of $880.39 million and offers a dividend yield of 5.65%, reflecting investor caution amid its financial challenges.
FMC Corporation drastically cut its Q3 2026 revenue outlook from $840-$900 million to just $65-$125 million, causing its shares to fall between 31% and 46%. This sharp revision followed the company's recent $403 million stock sale and $1.2 billion se...
FMC sharply cut its Q3 2026 revenue forecast to $65-$125 million from $840-$900 million and now expects an adjusted EBITDA loss of $510-$565 million, down from a prior profit forecast. The company cited weak demand and excess inventories of higher-pr...
Block & Leviton LLP is investigating FMC Corporation for potentially misleading investors about unsold inventory of higher-priced products. After the third quarter, FMC reported expected revenue far below estimates and a large adjusted EBITDA loss, i...
Block & Leviton is investigating FMC Corporation for potentially misleading investors about unsold inventory of higher-priced products. FMC recently revised its quarterly revenue forecast down to $65-$125 million and reported a large adjusted EBITDA ...
FMC Corporation updated its third-quarter outlook, projecting revenue between $65 million and $125 million and a significantly negative Adjusted EBITDA ranging from -$565 million to -$510 million. The company cited weaker-than-expected demand and hig...
